All Posts
Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic
16 Oct, 2020 | 09:38h | UTCSensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA
Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic
Commentary on Twitter
https://twitter.com/seymoc/status/1316765788523511809
Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign
16 Oct, 2020 | 09:37h | UTC
Commentary on Twitter
Profile of @trishgreenhalgh, whose laudable and herculean efforts have favorably influenced our response to the pandemic @ScienceMagazine @UniofOxford https://t.co/t4yTFgmbr2 by @EllenRuppelShel
“As scientists, our goal must be to cut through the rubbish.”— Eric Topol (@EricTopol) October 15, 2020
Researchers worldwide fight to work and teach amid COVID-19
16 Oct, 2020 | 09:35h | UTCResearchers worldwide fight to work and teach amid COVID-19 – Nature
NEW Special issue of The Global Burden of Disease Study 2019
16 Oct, 2020 | 09:31h | UTCHomepage: Global Burden of Disease Study 2019 – The Lancet
Editorial: Global health: time for radical change? – The Lancet
Commentary on Twitter
NEW Special issue of #GBDStudy 2019: 286 causes of death, 369 diseases & injuries, 87 risk factors in 204 countries & territories—data reveal how the world’s population was prepared in terms of underlying health for #COVID19 pandemic https://t.co/Af7hOlLFoJ pic.twitter.com/9kSeyB77Fv
— The Lancet (@TheLancet) October 15, 2020
Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19
16 Oct, 2020 | 09:34h | UTC
Commentary on Twitter
Just updated: @CochraneCollab living review investigates the use of convalescent plasma to treat people with COVID-19: https://t.co/Or5qmxki8H “We remain very uncertain about the effectiveness & safety of using convalescent plasma for people with #COVID19".
— The Cochrane Library (@CochraneLibrary) October 13, 2020
Review: Why and how vaccines work
16 Oct, 2020 | 09:32h | UTCWhy and How Vaccines Work – Cell
Commentary on Twitter
Why and how vaccines work, including how the covid-19 vaccines are positioned, new adjuvants
New @CellCellPress by @VirusesImmunity and @SaadOmer3 https://t.co/ydGfLJh0Uv pic.twitter.com/8niIaMVlAQ— Eric Topol (@EricTopol) October 15, 2020
Life expectancy after bariatric surgery in the Swedish Obese Subjects Study
16 Oct, 2020 | 09:29h | UTCCommentary: Higher average life expectancy after obesity surgery – University of Gothenburg
Commentary on Twitter
https://twitter.com/NEJM/status/1316816109279084545
[Abstract Only] Randomized trial: Upadacitinib vs. Abatacept in rheumatoid arthritis
16 Oct, 2020 | 09:28h | UTCTrial of Upadacitinib or Abatacept in Rheumatoid Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Rheumatoid Arthritis: When DMARDs Fail, Can JAK Inhibitors Step In? – Physician’s Weekly
Systematic review: Management of colonic diverticulitis
16 Oct, 2020 | 09:25h | UTCManagement of Colonic Diverticulitis – Agency for Healthcare Research and Quality
Full report: Management of Colonic Diverticulitis
Evidence summary: Management of Colonic Diverticulitis
Study: Negative D-dimer safely rules out DVT as a stand-alone test
16 Oct, 2020 | 09:26h | UTCNegative D-dimer safely ruled out DVT as a stand-alone test – Blood Advances
Randomized trial: Effect of sustained smoking cessation counseling and free medication vs. shorter-term counseling and medication advice on smoking abstinence
16 Oct, 2020 | 09:23h | UTCCommentary: Long-term, frequent phone counseling helps cancer patients who smoke quit – eCancer
Review: Evaluation and treatment of patients with hypercortisolism
16 Oct, 2020 | 09:24h | UTCEvaluation and Treatment of Patients With Hypercortisolism: A Review – JAMA Surgery
IDSA Position Statement: “Herd immunity” is not an answer to a pandemic
15 Oct, 2020 | 09:31h | UTC“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America
Commentary on Twitter
https://t.co/k15V8bMjiK via @IDSAInfo Excellent statement from @IDSAInfo & @HIVMA Presidents of why "herd immunity" is not an answer to a pandemic. These is the professional association representing > 12K specialists in infectious diseases so these are the real experts!
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Updated Cochrane Review shows electronic cigarettes can help people quit smoking
16 Oct, 2020 | 09:21h | UTCUpdated Cochrane Review shows electronic cigarettes can help people quit smoking – Cochrane Library
Original study: Electronic cigarettes for smoking cessation – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1316475634445672448
Perspective: Will SARS-CoV-2 become endemic?
15 Oct, 2020 | 09:29h | UTCWill SARS-CoV-2 become endemic? – Science
Commentary on Twitter
Whether #SARSCoV2 reinfections will be commonplace and how often they will occur remain to be understood, say authors in this Perspective. They also discuss what factors could drive the resultant pattern of endemicity if reinfection does become common. https://t.co/POKQ2byTYB pic.twitter.com/FMNbB8QR6p
— Science Magazine (@ScienceMagazine) October 14, 2020
Living with the COVID-19 pandemic: Act now with the tools we have
15 Oct, 2020 | 09:22h | UTCLiving with the COVID-19 pandemic: act now with the tools we have – The Lancet
Commentary on Twitter
NEW—Living with the #COVID19 pandemic: act now with the tools we have
J Bedford et al, @WHO STAG-IH, share a checklist for an epidemiologically based public health response to COVID-19, which is "neglected or inappropriately understood in some countries" https://t.co/vhjY0MsekB pic.twitter.com/Vb3B8OJNjr
— The Lancet (@TheLancet) October 9, 2020
Review: The duration of infectiousness of individuals infected with SARS-CoV-2
15 Oct, 2020 | 09:26h | UTCThe duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection
Commentary on Twitter
🔥NEW Review🔥#COVID19 pts with mild-to-moderate illness are highly unlikely to be infectious beyond 10 ds from symptom onset , However, limited studies found that Immunocompromised and severe-to-critical patients may be infectious for >10 days https://t.co/hogXvFpPEb pic.twitter.com/fBm5Se4RBf
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 13, 2020
Pediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: An overview
15 Oct, 2020 | 09:21h | UTC
Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts
15 Oct, 2020 | 09:17h | UTC
The 4 simple reasons Germany is managing Covid-19 better than its neighbors
15 Oct, 2020 | 09:19h | UTCThe 4 simple reasons Germany is managing Covid-19 better than its neighbors – Vox
See also: The German coronavirus mystery – UnHerd
WHO Global tuberculosis report 2020
15 Oct, 2020 | 09:35h | UTCGlobal tuberculosis report 2020 – World Health Organization
News release: WHO: Global TB progress at risk – World Health Organization
Executive summary: Global tuberculosis report 2020
Commentary: WHO warns of COVID impact on TB services – CIDRAP
Commentary on Twitter
The 🌏🌍🌏 has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop in deaths between 2015 and 2019.
🚨 #COVID19 will lead to setbacks if no action is taken urgently, according to 🆕 WHO report 👉https://t.co/5BvbGjaudU pic.twitter.com/A4edYfyOBH
— World Health Organization (WHO) (@WHO) October 14, 2020
Cluster randomized trial: Incentive programs for smoking cessation
15 Oct, 2020 | 09:09h | UTC
Commentary on Twitter
NEW paper @bmj_latest: #RCT of multiple incentive types for #smoking cessation in worksites in Thailand (SMILE trial). Large individual bonus most effective. https://t.co/CNdvhOo7Sb
With @WilliamHDow @c_lowenstein @UCBerkeleySPH and Aree Jampklay, Nucharee Srivirojana @MahidolU pic.twitter.com/q9B61wyzrf
— Justin White (@justinswhite) October 14, 2020
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society–USA Panel
15 Oct, 2020 | 09:13h | UTC
Commentary on Twitter
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults https://t.co/J3zHm9rpkY via @JAMA_current The new @IAS_USA ART guidelines document is out. Enormous effort led by @msaagmd with @RMKGandhi @doc_in_a_box @drmt @PaulSaxMD @joseph_eron and others on panel.
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Phase 3 trials show positive results for cefiderocol, but questions remain
15 Oct, 2020 | 09:07h | UTCPhase 3 trials show positive results for cefiderocol, but questions remain – CIDRAP
Five things clinicians and patients should question in public health
15 Oct, 2020 | 09:05h | UTCFive Things Clinicians and Patients Should Question – Choosing Wisely Canada
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada


